Ovarian Cancer

The ovaries are part of the female reproductive system. Women have two ovaries, which are the main source of estrogen and progesterone. Ovarian cancer is one of the most common malignant tumors in female reproductive cancers, and its incidence is second only to cervical cancer. Ovarian cancer poses a serious threat to women's lives, and the vast majority of cases occur in women over 50. Ovarian cancer is divided into different categories according to different histological sources, including epithelial tumors, germ cell tumors, and sexostromal tumors, among which epithelial tumors are the most common. The cause of ovarian cancer is not clear, it may be related to heredity, hormones, gynecological diseases, fertility factors, and lifestyle habits.

Diagnosis of Ovarian Cancer

The following tests can be used to diagnose ovarian cancer:

Pelvic examination. During a pelvic examination, initially check the uterus, vagina, ovaries, bladder and rectum for abnormal changes such as lumps.

Tumor marker test. Tumor markers include CA125, HE4, ROMA index, alpha-fetoprotein (AFP), B-human chorionic gonadotropin (B-HCG), neuron-specific enolase (NSE), lactate dehydrogenase (LDH), CA199, CA153 and carcinoembryonic antigen (CEA), etc. Among them, CA125 is the most commonly used tumor marker for epithelial ovarian cancer. About 80% of patients with epithelial ovarian cancer may significantly increase in CA125. A high level of CA125 in the blood may be a sign of ovarian cancer.

Imaging diagnosis. Through ultrasound, MRI, CT, PET-CT, mammography and laparoscopy, etc., ovarian cancer is further diagnosed.

Advantages of Our Products

Creative Biogene's ovarian cancer diagnostic products are mainly developed to target tumor markers and some ovarian cancer antibodies. Our products are characterized by high sensitivity, accuracy and reproducibility.

Creative Biogene's skilled scientists have extensive experience in developing diagnostic products for ovarian cancer. Our products are competitive in the market due to their reasonable price and high quality, which can help you solve the diagnosis problem quickly. We look forward to working with you for your cooperation.

Please contact us for more details.

References

1. Wang J, et al. (2014). "Diagnostic accuracy of serum HE4, CA125 and ROMA in patients with ovarian cancer: a meta-analysis." Tumor Biology. 35.6:6127-6138.
2. Hamed O, et al. (2013). "Significance of HE4 estimation in comparison with CA125 in diagnosis of ovarian cancer and assessment of treatment response." Diagnostic Pathology. 8.1: 11.